Skip to main content
Top
Published in: Rheumatology International 1/2022

01-01-2022 | Colchicine | Case Based Review

Familial coexistence of demyelinating diseases and familial Mediterranean fever

Authors: Cengiz Korkmaz, Döndü Üsküdar Cansu, Sibel Canbaz Kabay

Published in: Rheumatology International | Issue 1/2022

Login to get access

Abstract

Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease characterized by fever and serositis attacks caused by mutations in the MEditerranean FeVer (MEFV) gene encoding the pyrin gene. Gain of the function mutations of the pyrin gene lead to stimulation of pro-inflammatory cytokines. Persistent pro-inflammatory situation in the course of FMF may play a role in the development of some other inflammatory diseases such as Behcet’s disease, psoriasis, and vasculitis. Multiple sclerosis (MS), as a demyelinating disorder, is also more commonly seen in FMF patients compared to the general population. There are scarcely any research reporting that these two diseases coexist in more than one person in the same family. We have discovered cases of FMF and demyelinating disorders in five members of two different families. Besides the two families we are reporting, there are only four other families reported so far. Having combined the data of all these six families, we present a case-based review in this study. We aimed to draw attention of physicians to familial co-occurence of FMF and demyelinating disorders and also to discuss possible mechanisms of the coexistence of these two diseases in light of the literature.
Literature
2.
go back to reference Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrininflammasome activation and RhoAsignaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921CrossRef Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrininflammasome activation and RhoAsignaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921CrossRef
3.
go back to reference Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81CrossRef Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81CrossRef
4.
go back to reference Tunca M, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Topaloglu R et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11CrossRef Tunca M, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Topaloglu R et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11CrossRef
5.
go back to reference Ozdogan H, Arisoy N, Kasapçapur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed Ozdogan H, Arisoy N, Kasapçapur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327PubMed
6.
go back to reference Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F et al (2013) High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther 28(15):R21CrossRef Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F et al (2013) High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther 28(15):R21CrossRef
7.
go back to reference Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö et al (2020) Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford) 1(59):1372–1380CrossRef Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö et al (2020) Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford) 1(59):1372–1380CrossRef
8.
go back to reference Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O et al (2020) Evaluation of co-existing diseases in children with familial Mediterranean fever. RheumatolInt 40:57–64CrossRef Yildiz M, Adrovic A, Tasdemir E, Baba-Zada K, Aydin M, Koker O et al (2020) Evaluation of co-existing diseases in children with familial Mediterranean fever. RheumatolInt 40:57–64CrossRef
9.
go back to reference Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A et al (2009) Clinical Disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60:1862–1866CrossRef Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A et al (2009) Clinical Disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60:1862–1866CrossRef
10.
go back to reference Akman-Demir G, Gül A, Gürol E, Özdoğan H, Bahar S et al (2006) Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 253:928–934CrossRef Akman-Demir G, Gül A, Gürol E, Özdoğan H, Bahar S et al (2006) Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 253:928–934CrossRef
11.
12.
go back to reference Kümpfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, Krumbholz M et al (2012) Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis. Mult Scler 18:1229–1238CrossRef Kümpfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, Krumbholz M et al (2012) Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis. Mult Scler 18:1229–1238CrossRef
13.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885CrossRef Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885CrossRef
14.
go back to reference McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRef McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRef
15.
go back to reference Yildirim ME, Kurtulgan HK, Ozdemir O, Kilicgun H, Aydemir DS, Baser B, Sezgin I (2019) Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia. Ann Saudi Med 39:382–387CrossRef Yildirim ME, Kurtulgan HK, Ozdemir O, Kilicgun H, Aydemir DS, Baser B, Sezgin I (2019) Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia. Ann Saudi Med 39:382–387CrossRef
16.
go back to reference Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S (2018) Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. MultSclerRelatDisord 20:43–47 Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S (2018) Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. MultSclerRelatDisord 20:43–47
17.
go back to reference Unal A, Dursun A, Emre U, Tascilar NF, Ankarali H (2010) Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene? J NeurolSci 294(1–2):38–42 Unal A, Dursun A, Emre U, Tascilar NF, Ankarali H (2010) Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene? J NeurolSci 294(1–2):38–42
18.
go back to reference Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A (2003) Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 4:197–203CrossRef Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A (2003) Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 4:197–203CrossRef
19.
go back to reference Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467Y478CrossRef Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467Y478CrossRef
20.
go back to reference Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40:1735–1739CrossRef Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40:1735–1739CrossRef
22.
go back to reference de Jong BA, Huizinga TW, Bollen EL, Uitdehaag BM, Bosma GP, van Buchem MA et al (2002) Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 126(1–2):172–179CrossRef de Jong BA, Huizinga TW, Bollen EL, Uitdehaag BM, Bosma GP, van Buchem MA et al (2002) Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 126(1–2):172–179CrossRef
23.
go back to reference Cree BAC (2014) Handbook of Clinical Neurology. In: Godin DS (ed) Multiple sclerosis genetics, 3rd edn. Elsevier, US San Francisco, pp 193–209 Cree BAC (2014) Handbook of Clinical Neurology. In: Godin DS (ed) Multiple sclerosis genetics, 3rd edn. Elsevier, US San Francisco, pp 193–209
24.
go back to reference Mahfouz R, Kreidieh K, Khalek RA, Yazbek S (2017) Familial Mediterranean fever: observations from a pilot gene expression microarray analysis study. Cell MolBiol 63:26–28 (Noisy-le-grand) Mahfouz R, Kreidieh K, Khalek RA, Yazbek S (2017) Familial Mediterranean fever: observations from a pilot gene expression microarray analysis study. Cell MolBiol 63:26–28 (Noisy-le-grand)
25.
go back to reference Kinikli G, Bektas M, Mısırlıoğlu M, Ates A, Turgay M, Tuncer S et al (2005) Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial mediterranean fever (FMF) patients. Turk J Gastroenterol 16:143–146PubMed Kinikli G, Bektas M, Mısırlıoğlu M, Ates A, Turgay M, Tuncer S et al (2005) Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial mediterranean fever (FMF) patients. Turk J Gastroenterol 16:143–146PubMed
26.
go back to reference Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651CrossRef Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651CrossRef
27.
go back to reference Siegal S (1964) Familial paroxysmal polyserositis. Analysis of fifty cases. Am J Med 36:893–918CrossRef Siegal S (1964) Familial paroxysmal polyserositis. Analysis of fifty cases. Am J Med 36:893–918CrossRef
28.
go back to reference Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36:109–120CrossRef Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36:109–120CrossRef
29.
go back to reference Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328(7442):731CrossRef Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328(7442):731CrossRef
30.
go back to reference Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS (1988) Stress and its relationship to acute exacerbations in multiple sclerosis. J NeurolRehabilit 2:7–11 Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS (1988) Stress and its relationship to acute exacerbations in multiple sclerosis. J NeurolRehabilit 2:7–11
Metadata
Title
Familial coexistence of demyelinating diseases and familial Mediterranean fever
Authors
Cengiz Korkmaz
Döndü Üsküdar Cansu
Sibel Canbaz Kabay
Publication date
01-01-2022
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 1/2022
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04821-7

Other articles of this Issue 1/2022

Rheumatology International 1/2022 Go to the issue

Acknowledgement to Referees

Acknowledgement to referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine